Patents

US 12209111 B2: Targeting P18 for mTOR-related disorders

Granted
2025-01-28
Filed
2019-05-31 application 17059882
Type
Utility · 7 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Accumulating evidence indicates that the lysosomal Ragulator complex is essential for full activation of the mechanistic target of rapamycin complex 1 (mTORC1). Abnormal mTORC1 activation has been implicated in several developmental neurological disorders, including Angelman syndrome (AS), which is caused by maternal deficiency of the ubiquitin E3 ligase UBE3A. Here, it is reported that Ube3a regulates mTORC1 signaling by targeting p18, a subunit of the Ragulator. Ube3a ubiquinates p18, resulting in its proteasomal degradation, and Ube3a deficiency in the hippocampus of AS mice induces increased lysosomal localization of p18 and other members of the Ragulator-Rag complex, and increased mTORC1 activity. p18 knockdown in hippocampal CA1 neurons of AS mice reduces elevated mTORC1 activity and improves dendritic spine maturation, long-term potentiation (LTP), as well as learning performance. The results described herein indicate that Ube3a-mediated regulation of p18 and subsequent mTORC1 signaling is critical for typical synaptic plasticity, dendritic spine development, and learning and memory.

Source: PVGPATDIS, file of 2026-04-10 (ipg250128.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
WESTERN UNIVERSITY OF HEALTH SCIENCES 19 patentsUS company or organizationPomona, CAWESTERN UNIVERSITY OF HEALTH SCIENCES State business registration EXACT high confidence: identical full name and state
Western University of Health Sciences College or university EXACT high confidence: identical full name and state
WESTERN UNIVERSITY OF HEALTH SCIENCES Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Xiaoning BiCorona, CA1PVGPATDIS, file of 2026-04-10
Michel BaudryCorona, CA3PVGPATDIS, file of 2026-04-10
Jiandong SunChino Hills, CA5PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K14/4703PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P25/00PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/113PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K38/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2021-04-21Assignment
Assignment of assignor's interest
BAUDRY, MICHEL signed 2021-02-23
BI, XIAONING signed 2021-02-23
SUN, JIANDONG signed 2021-02-23
WESTERN UNIVERSITY OF HEALTH SCIENCES POMONA, CA55986/821ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.